Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors Article Swipe
Jeroen Slaats
,
Esther Wagena
,
Daan Smits
,
Annemarie A. Berends
,
Ella Peters
,
Gert‐Jan Bakker
,
Merijn van Erp
,
Bettina Weigelin
,
Gosse J. Adema
,
Peter Friedl
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.22545873.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.22545873.v1
Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors
Related Topics
Concepts
Antagonism
Cytotoxicity
Cytotoxic T cell
Adenosine A2A receptor
Adenosine
Adenosine receptor
Pharmacology
Chemistry
Receptor
Biology
Cancer research
Biochemistry
In vitro
Agonist
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- http://doi.org/10.1158/2326-6066.22545873.v1
- OA Status
- gold
- References
- 50
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362543517
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362543517Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/2326-6066.22545873.v1Digital Object Identifier
- Title
-
Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed TumorsWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-04Full publication date if available
- Authors
-
Jeroen Slaats, Esther Wagena, Daan Smits, Annemarie A. Berends, Ella Peters, Gert‐Jan Bakker, Merijn van Erp, Bettina Weigelin, Gosse J. Adema, Peter FriedlList of authors in order
- Landing page
-
https://doi.org/10.1158/2326-6066.22545873.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/2326-6066.22545873.v1Direct OA link when available
- Concepts
-
Antagonism, Cytotoxicity, Cytotoxic T cell, Adenosine A2A receptor, Adenosine, Adenosine receptor, Pharmacology, Chemistry, Receptor, Biology, Cancer research, Biochemistry, In vitro, AgonistTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
50Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362543517 |
|---|---|
| doi | https://doi.org/10.1158/2326-6066.22545873.v1 |
| ids.doi | https://doi.org/10.1158/2326-6066.22545873.v1 |
| ids.openalex | https://openalex.org/W4362543517 |
| fwci | 0.0 |
| type | preprint |
| title | Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11193 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1314 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Adenosine and Purinergic Signaling |
| topics[1].id | https://openalex.org/T11491 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9970999956130981 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | CAR-T cell therapy research |
| topics[2].id | https://openalex.org/T10158 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9940000176429749 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Immunotherapy and Biomarkers |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777383412 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9576056599617004 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q4770891 |
| concepts[0].display_name | Antagonism |
| concepts[1].id | https://openalex.org/C109316439 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8902871012687683 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q246181 |
| concepts[1].display_name | Cytotoxicity |
| concepts[2].id | https://openalex.org/C154317977 |
| concepts[2].level | 3 |
| concepts[2].score | 0.8121182918548584 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q376266 |
| concepts[2].display_name | Cytotoxic T cell |
| concepts[3].id | https://openalex.org/C2778491162 |
| concepts[3].level | 5 |
| concepts[3].score | 0.5623722672462463 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3063865 |
| concepts[3].display_name | Adenosine A2A receptor |
| concepts[4].id | https://openalex.org/C2776991684 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5416709184646606 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q190012 |
| concepts[4].display_name | Adenosine |
| concepts[5].id | https://openalex.org/C67907053 |
| concepts[5].level | 4 |
| concepts[5].score | 0.48009756207466125 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q356147 |
| concepts[5].display_name | Adenosine receptor |
| concepts[6].id | https://openalex.org/C98274493 |
| concepts[6].level | 1 |
| concepts[6].score | 0.457878053188324 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[6].display_name | Pharmacology |
| concepts[7].id | https://openalex.org/C185592680 |
| concepts[7].level | 0 |
| concepts[7].score | 0.44542351365089417 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[7].display_name | Chemistry |
| concepts[8].id | https://openalex.org/C170493617 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4292261004447937 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[8].display_name | Receptor |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.3927091062068939 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C502942594 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3813214898109436 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[10].display_name | Cancer research |
| concepts[11].id | https://openalex.org/C55493867 |
| concepts[11].level | 1 |
| concepts[11].score | 0.27685546875 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[11].display_name | Biochemistry |
| concepts[12].id | https://openalex.org/C202751555 |
| concepts[12].level | 2 |
| concepts[12].score | 0.16901978850364685 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[12].display_name | In vitro |
| concepts[13].id | https://openalex.org/C2778938600 |
| concepts[13].level | 3 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q389934 |
| concepts[13].display_name | Agonist |
| keywords[0].id | https://openalex.org/keywords/antagonism |
| keywords[0].score | 0.9576056599617004 |
| keywords[0].display_name | Antagonism |
| keywords[1].id | https://openalex.org/keywords/cytotoxicity |
| keywords[1].score | 0.8902871012687683 |
| keywords[1].display_name | Cytotoxicity |
| keywords[2].id | https://openalex.org/keywords/cytotoxic-t-cell |
| keywords[2].score | 0.8121182918548584 |
| keywords[2].display_name | Cytotoxic T cell |
| keywords[3].id | https://openalex.org/keywords/adenosine-a2a-receptor |
| keywords[3].score | 0.5623722672462463 |
| keywords[3].display_name | Adenosine A2A receptor |
| keywords[4].id | https://openalex.org/keywords/adenosine |
| keywords[4].score | 0.5416709184646606 |
| keywords[4].display_name | Adenosine |
| keywords[5].id | https://openalex.org/keywords/adenosine-receptor |
| keywords[5].score | 0.48009756207466125 |
| keywords[5].display_name | Adenosine receptor |
| keywords[6].id | https://openalex.org/keywords/pharmacology |
| keywords[6].score | 0.457878053188324 |
| keywords[6].display_name | Pharmacology |
| keywords[7].id | https://openalex.org/keywords/chemistry |
| keywords[7].score | 0.44542351365089417 |
| keywords[7].display_name | Chemistry |
| keywords[8].id | https://openalex.org/keywords/receptor |
| keywords[8].score | 0.4292261004447937 |
| keywords[8].display_name | Receptor |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.3927091062068939 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/cancer-research |
| keywords[10].score | 0.3813214898109436 |
| keywords[10].display_name | Cancer research |
| keywords[11].id | https://openalex.org/keywords/biochemistry |
| keywords[11].score | 0.27685546875 |
| keywords[11].display_name | Biochemistry |
| keywords[12].id | https://openalex.org/keywords/in-vitro |
| keywords[12].score | 0.16901978850364685 |
| keywords[12].display_name | In vitro |
| language | en |
| locations[0].id | doi:10.1158/2326-6066.22545873.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | http://doi.org/10.1158/2326-6066.22545873.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22545873 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Image |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/figure/Supplementary_Figure_from_Adenosine_A2a_Receptor_Antagonism_Restores_Additive_Cytotoxicity_by_Cytotoxic_T_Cells_in_Metabolically_Perturbed_Tumors/22545873 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5076370806 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-3800-3138 |
| authorships[0].author.display_name | Jeroen Slaats |
| authorships[0].countries | NL |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[0].institutions[0].id | https://openalex.org/I4210109357 |
| authorships[0].institutions[0].ror | https://ror.org/01yb10j39 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I145872427, https://openalex.org/I4210109357 |
| authorships[0].institutions[0].country_code | NL |
| authorships[0].institutions[0].display_name | Radboud Institute for Molecular Life Sciences |
| authorships[0].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[0].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[0].institutions[1].country_code | NL |
| authorships[0].institutions[1].display_name | Radboud University Medical Center |
| authorships[0].institutions[2].id | https://openalex.org/I145872427 |
| authorships[0].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[0].institutions[2].type | education |
| authorships[0].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[0].institutions[2].country_code | NL |
| authorships[0].institutions[2].display_name | Radboud University Nijmegen |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jeroen Slaats |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[1].author.id | https://openalex.org/A5077005500 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Esther Wagena |
| authorships[1].countries | NL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[1].institutions[0].id | https://openalex.org/I4210109357 |
| authorships[1].institutions[0].ror | https://ror.org/01yb10j39 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I145872427, https://openalex.org/I4210109357 |
| authorships[1].institutions[0].country_code | NL |
| authorships[1].institutions[0].display_name | Radboud Institute for Molecular Life Sciences |
| authorships[1].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[1].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[1].institutions[1].country_code | NL |
| authorships[1].institutions[1].display_name | Radboud University Medical Center |
| authorships[1].institutions[2].id | https://openalex.org/I145872427 |
| authorships[1].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[1].institutions[2].type | education |
| authorships[1].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[1].institutions[2].country_code | NL |
| authorships[1].institutions[2].display_name | Radboud University Nijmegen |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Esther Wagena |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[2].author.id | https://openalex.org/A5083969796 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3090-4321 |
| authorships[2].author.display_name | Daan Smits |
| authorships[2].countries | NL |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[2].institutions[0].id | https://openalex.org/I4210109357 |
| authorships[2].institutions[0].ror | https://ror.org/01yb10j39 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I145872427, https://openalex.org/I4210109357 |
| authorships[2].institutions[0].country_code | NL |
| authorships[2].institutions[0].display_name | Radboud Institute for Molecular Life Sciences |
| authorships[2].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[2].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[2].institutions[1].country_code | NL |
| authorships[2].institutions[1].display_name | Radboud University Medical Center |
| authorships[2].institutions[2].id | https://openalex.org/I145872427 |
| authorships[2].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[2].institutions[2].type | education |
| authorships[2].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[2].institutions[2].country_code | NL |
| authorships[2].institutions[2].display_name | Radboud University Nijmegen |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Daan Smits |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[3].author.id | https://openalex.org/A5006146706 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5124-8821 |
| authorships[3].author.display_name | Annemarie A. Berends |
| authorships[3].countries | NL |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[3].institutions[0].id | https://openalex.org/I4210109357 |
| authorships[3].institutions[0].ror | https://ror.org/01yb10j39 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I145872427, https://openalex.org/I4210109357 |
| authorships[3].institutions[0].country_code | NL |
| authorships[3].institutions[0].display_name | Radboud Institute for Molecular Life Sciences |
| authorships[3].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[3].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[3].institutions[1].country_code | NL |
| authorships[3].institutions[1].display_name | Radboud University Medical Center |
| authorships[3].institutions[2].id | https://openalex.org/I145872427 |
| authorships[3].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[3].institutions[2].type | education |
| authorships[3].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[3].institutions[2].country_code | NL |
| authorships[3].institutions[2].display_name | Radboud University Nijmegen |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Annemarie A. Berends |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[4].author.id | https://openalex.org/A5031426836 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3622-8475 |
| authorships[4].author.display_name | Ella Peters |
| authorships[4].countries | NL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[4].institutions[0].id | https://openalex.org/I4210109357 |
| authorships[4].institutions[0].ror | https://ror.org/01yb10j39 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I145872427, https://openalex.org/I4210109357 |
| authorships[4].institutions[0].country_code | NL |
| authorships[4].institutions[0].display_name | Radboud Institute for Molecular Life Sciences |
| authorships[4].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[4].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[4].institutions[1].country_code | NL |
| authorships[4].institutions[1].display_name | Radboud University Medical Center |
| authorships[4].institutions[2].id | https://openalex.org/I145872427 |
| authorships[4].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[4].institutions[2].type | education |
| authorships[4].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[4].institutions[2].country_code | NL |
| authorships[4].institutions[2].display_name | Radboud University Nijmegen |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ella Peters |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[5].author.id | https://openalex.org/A5082642221 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3602-0014 |
| authorships[5].author.display_name | Gert‐Jan Bakker |
| authorships[5].countries | NL |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[5].institutions[0].id | https://openalex.org/I4210109357 |
| authorships[5].institutions[0].ror | https://ror.org/01yb10j39 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I145872427, https://openalex.org/I4210109357 |
| authorships[5].institutions[0].country_code | NL |
| authorships[5].institutions[0].display_name | Radboud Institute for Molecular Life Sciences |
| authorships[5].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[5].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[5].institutions[1].country_code | NL |
| authorships[5].institutions[1].display_name | Radboud University Medical Center |
| authorships[5].institutions[2].id | https://openalex.org/I145872427 |
| authorships[5].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[5].institutions[2].type | education |
| authorships[5].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[5].institutions[2].country_code | NL |
| authorships[5].institutions[2].display_name | Radboud University Nijmegen |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Gert-Jan Bakker |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[6].author.id | https://openalex.org/A5067213239 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9642-9789 |
| authorships[6].author.display_name | Merijn van Erp |
| authorships[6].countries | NL |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[6].institutions[0].id | https://openalex.org/I4210109357 |
| authorships[6].institutions[0].ror | https://ror.org/01yb10j39 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I145872427, https://openalex.org/I4210109357 |
| authorships[6].institutions[0].country_code | NL |
| authorships[6].institutions[0].display_name | Radboud Institute for Molecular Life Sciences |
| authorships[6].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[6].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[6].institutions[1].country_code | NL |
| authorships[6].institutions[1].display_name | Radboud University Medical Center |
| authorships[6].institutions[2].id | https://openalex.org/I145872427 |
| authorships[6].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[6].institutions[2].type | education |
| authorships[6].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[6].institutions[2].country_code | NL |
| authorships[6].institutions[2].display_name | Radboud University Nijmegen |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Merijn van Erp |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[7].author.id | https://openalex.org/A5019346530 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-4460-3113 |
| authorships[7].author.display_name | Bettina Weigelin |
| authorships[7].countries | NL |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[7].affiliations[1].raw_affiliation_string | Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of T€ ubingen, T€ ubingen, Germany. |
| authorships[7].affiliations[2].raw_affiliation_string | Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls Uni-versity T€ ubingen, T€ ubingen, Germany. |
| authorships[7].institutions[0].id | https://openalex.org/I4210109357 |
| authorships[7].institutions[0].ror | https://ror.org/01yb10j39 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I145872427, https://openalex.org/I4210109357 |
| authorships[7].institutions[0].country_code | NL |
| authorships[7].institutions[0].display_name | Radboud Institute for Molecular Life Sciences |
| authorships[7].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[7].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[7].institutions[1].country_code | NL |
| authorships[7].institutions[1].display_name | Radboud University Medical Center |
| authorships[7].institutions[2].id | https://openalex.org/I145872427 |
| authorships[7].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[7].institutions[2].type | education |
| authorships[7].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[7].institutions[2].country_code | NL |
| authorships[7].institutions[2].display_name | Radboud University Nijmegen |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Bettina Weigelin |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of T€ ubingen, T€ ubingen, Germany., Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands., Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls Uni-versity T€ ubingen, T€ ubingen, Germany. |
| authorships[8].author.id | https://openalex.org/A5015323424 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-6750-1665 |
| authorships[8].author.display_name | Gosse J. Adema |
| authorships[8].countries | NL |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949 |
| authorships[8].affiliations[0].raw_affiliation_string | Radiotherapy and Onco-Immunology Labora-tory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[8].institutions[0].id | https://openalex.org/I2802934949 |
| authorships[8].institutions[0].ror | https://ror.org/05wg1m734 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I2802934949 |
| authorships[8].institutions[0].country_code | NL |
| authorships[8].institutions[0].display_name | Radboud University Medical Center |
| authorships[8].institutions[1].id | https://openalex.org/I145872427 |
| authorships[8].institutions[1].ror | https://ror.org/016xsfp80 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I145872427 |
| authorships[8].institutions[1].country_code | NL |
| authorships[8].institutions[1].display_name | Radboud University Nijmegen |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Gosse J. Adema |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Radiotherapy and Onco-Immunology Labora-tory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[9].author.id | https://openalex.org/A5026527299 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0119-4041 |
| authorships[9].author.display_name | Peter Friedl |
| authorships[9].countries | NL, US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1343551460 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Genitourinary Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas. |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| authorships[9].affiliations[1].raw_affiliation_string | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands. |
| authorships[9].institutions[0].id | https://openalex.org/I4210109357 |
| authorships[9].institutions[0].ror | https://ror.org/01yb10j39 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I145872427, https://openalex.org/I4210109357 |
| authorships[9].institutions[0].country_code | NL |
| authorships[9].institutions[0].display_name | Radboud Institute for Molecular Life Sciences |
| authorships[9].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[9].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[9].institutions[1].country_code | NL |
| authorships[9].institutions[1].display_name | Radboud University Medical Center |
| authorships[9].institutions[2].id | https://openalex.org/I145872427 |
| authorships[9].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[9].institutions[2].type | education |
| authorships[9].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[9].institutions[2].country_code | NL |
| authorships[9].institutions[2].display_name | Radboud University Nijmegen |
| authorships[9].institutions[3].id | https://openalex.org/I1343551460 |
| authorships[9].institutions[3].ror | https://ror.org/04twxam07 |
| authorships[9].institutions[3].type | healthcare |
| authorships[9].institutions[3].lineage | https://openalex.org/I1343551460 |
| authorships[9].institutions[3].country_code | US |
| authorships[9].institutions[3].display_name | The University of Texas MD Anderson Cancer Center |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Peter Friedl |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | Department of Cell Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, the Netherlands., Department of Genitourinary Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://doi.org/10.1158/2326-6066.22545873.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11193 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1314 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Adenosine and Purinergic Signaling |
| related_works | https://openalex.org/W3030859185, https://openalex.org/W1974998794, https://openalex.org/W2987313600, https://openalex.org/W1382943, https://openalex.org/W130088918, https://openalex.org/W2062660503, https://openalex.org/W2430034614, https://openalex.org/W2020168868, https://openalex.org/W2426680130, https://openalex.org/W1965742203 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/2326-6066.22545873.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | http://doi.org/10.1158/2326-6066.22545873.v1 |
| primary_location.id | doi:10.1158/2326-6066.22545873.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | http://doi.org/10.1158/2326-6066.22545873.v1 |
| publication_date | 2023-04-04 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2945715301, https://openalex.org/W2168786562, https://openalex.org/W2417678083, https://openalex.org/W2151090378, https://openalex.org/W2078780781, https://openalex.org/W2077786296, https://openalex.org/W3180247890, https://openalex.org/W2049429882, https://openalex.org/W1675343160, https://openalex.org/W2166572577, https://openalex.org/W2294313458, https://openalex.org/W3021864086, https://openalex.org/W2067000451, https://openalex.org/W2987822998, https://openalex.org/W2986950076, https://openalex.org/W4253950317, https://openalex.org/W2775177930, https://openalex.org/W4286856190, https://openalex.org/W2309691699, https://openalex.org/W2982691328, https://openalex.org/W2998870126, https://openalex.org/W2808790891, https://openalex.org/W2737082469, https://openalex.org/W2096522498, https://openalex.org/W2163905724, https://openalex.org/W2131938193, https://openalex.org/W3165603599, https://openalex.org/W1515383436, https://openalex.org/W2492596306, https://openalex.org/W2142935448, https://openalex.org/W1710481878, https://openalex.org/W3198677380, https://openalex.org/W2049601932, https://openalex.org/W3129998112, https://openalex.org/W2395676613, https://openalex.org/W1969170402, https://openalex.org/W2584913109, https://openalex.org/W2933080993, https://openalex.org/W2113661022, https://openalex.org/W2053918650, https://openalex.org/W2102478114, https://openalex.org/W2614885626, https://openalex.org/W2059654418, https://openalex.org/W2765132620, https://openalex.org/W1863453661, https://openalex.org/W2890795012, https://openalex.org/W3033331291, https://openalex.org/W2947019869, https://openalex.org/W2980015124, https://openalex.org/W2171332611 |
| referenced_works_count | 50 |
| abstract_inverted_index.T | 12 |
| abstract_inverted_index.by | 10 |
| abstract_inverted_index.in | 14 |
| abstract_inverted_index.A2a | 4 |
| abstract_inverted_index.from | 2 |
| abstract_inverted_index.Cells | 13 |
| abstract_inverted_index.Figure | 1 |
| abstract_inverted_index.Tumors | 17 |
| abstract_inverted_index.Additive | 8 |
| abstract_inverted_index.Receptor | 5 |
| abstract_inverted_index.Restores | 7 |
| abstract_inverted_index.Adenosine | 3 |
| abstract_inverted_index.Cytotoxic | 11 |
| abstract_inverted_index.Perturbed | 16 |
| abstract_inverted_index.Antagonism | 6 |
| abstract_inverted_index.Cytotoxicity | 9 |
| abstract_inverted_index.Metabolically | 15 |
| abstract_inverted_index.Supplementary | 0 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5026527299 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 10 |
| corresponding_institution_ids | https://openalex.org/I1343551460, https://openalex.org/I145872427, https://openalex.org/I2802934949, https://openalex.org/I4210109357 |
| citation_normalized_percentile.value | 0.14182217 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |